Results 111 to 120 of about 1,995 (245)
Cross-genotype immunogenicity and antibody-dependent enhancement of KD-382 dengue vaccine in flavivirus-naïve adults [PDF]
This exploratory study evaluated the neutralization breadth and potential antibody-dependent enhancement (ADE) risk following a single-dose of the KD-382 live-attenuated tetravalent dengue vaccine over 12 months in flavivirus-naïve healthy adults.
Abe, Motoharu +7 more
core +1 more source
A fibroblast activation protein (FAP)‐targeted small molecule–drug conjugate (SMDC) platform is developed to integrate PET imaging with synergistic radionuclide–chemotherapy. Linker chemistry governs stability, exposure, and tolerability, with the VC linker providing superior in vivo performance.
Ruitao Yang +6 more
wiley +1 more source
KEMAUAN MEMBAYAR (WILLINGNESS TO PAY VAKSIN DENGUE: TINJAUAN SISTEMATIS [PDF]
Vaksin dengue menjadi salah satu upaya pencegahan penyakit demam berdarah namun di Indonesia vaksin dengue tidak ditanggung pemerintah dan masih sedikit masyarakat yang berminat untuk melakukan vaksinasi dengue.
Endarti, Dwi +2 more
core +1 more source
A temporally controlled drug release coating is developed for abutments using a superhydrophobic coating self‐assembled on mesoporous silica. This surface provides sequential functionality: initial contamination resistance through non‐wetting, followed by controlled drug release via wettability transition.
Zhongchao Wang +8 more
wiley +1 more source
This research demonstrates that incorporating 10 wt.% NASICON‐type Na3Zr2Si2PO12 into Na3SbS4 sulfide electrolytes mitigates interfacial instability and structural defects. The resulting composite enhances ionic conductivity to 3.97 * 10−4 S cm−1 and reduces activation energy.
Celastin Bebina Thairiyarayar +4 more
wiley +1 more source
LITERATURE REVIEW: KAJIAN EFEKTIVITAS PERKEMBANGAN VAKSIN VIRUS DENGUE MASA KINI [PDF]
Dengue fever is a disease caused by the dengue virus (DENV) which often becomes a problem for public health in the world with approximately 390 million cases of infection.
Aulia, Tisa
core +1 more source
The dengue vaccine initiative: A bibliometric analysis of research publications [PDF]
Dengue fever has become a significant public health problem in tropical and subtropical regions and affects millions of people annually. Approximately 390 million people worldwide are estimated to be infected with dengue every year, of which 96 million ...
Mulakoli, Festus +2 more
core +2 more sources
Background: In trials, dengue vaccine efficacy evaluation relies on participants presenting with febrile illness/clinically suspected dengue contacting the study site for sample collection and clinical assessment within a short timeframe.
Harald Pfaar +8 more
doaj +1 more source
In‐host modeling of dengue virus and non‐structural protein 1 and the effects of ivermectin in patients with acute dengue fever [PDF]
The increased incidence of dengue poses a substantially global public health challenge. There are no approved antiviral drugs to treat dengue infections.
Angkasekwinai, Nasikarn +15 more
core +2 more sources
Selective Interfacial Barriers Drive High‐Performance GeTe Thermoelectrics
Carrier‐phonon decoupling is the key to developing high‐performance thermoelectric materials. Here, we demonstrate that selective interfacial barriers can decouple carrier and phonon transport, thus achieving an exceptional peak ZT of ∼2.7 at 773 K, along with a record‐high average ZT of 1.9 across 300–773 K in the (Ge0.82Mn0.04Bi0.04Pb0.1Te)0.99(VSe2 ...
Liang‐Cao Yin +12 more
wiley +1 more source

